share_log
Benzinga ·  Jul 9 04:11
On Monday, Johnson & Johnson Agreed To Pay $50M To Settle Claims Related To A Terminated Manufacturing Deal With Emergent BioSolutions Related To Johnson & Johnson's Covid-19 Vaccine - 8K
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment